SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$16.76
Tradestie Score
49
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+77.2%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$115.30
|
$16.93B | 15.5 | 56 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.16
|
$15.70B | 31.3 | 70 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.87
|
$12.36B | 17.9 | 66 | Compare |
|
EXEL
Exelixis Inc
|
$58.39
|
$11.09B | 18.2 | 43 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.72
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$190.01
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.18
|
$10.53B | 157.9 | 46 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$43.54
|
$10.49B | - | 71 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.25
|
$10.22B | - | 76 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$499.40
|
$10.01B | - | 54 | Compare |
More SMMT Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry